litlas
Log inCreate account

Theodore C. Pierson

Active 1997–2025

113
Papers
24,047
Citations
79
h-index
103
i10-index

Citations

Citations per year for Theodore C. Pierson1992: 1 citations1994: 3 citations1995: 1 citations1997: 2 citations1998: 48 citations1999: 69 citations2000: 88 citations2001: 72 citations2002: 100 citations2003: 103 citations2004: 86 citations2005: 109 citations2006: 87 citations2007: 133 citations2008: 148 citations2009: 170 citations2010: 174 citations2011: 245 citations2012: 190 citations2013: 222 citations2014: 185 citations2015: 186 citations2016: 313 citations2017: 487 citations2018: 458 citations2019: 1,014 citations2020: 1,162 citations2021: 1,061 citations2022: 719 citations2023: 507 citations2024: 750 citations2025: 383 citations2026: 7 citations1993: no citations, so this year is not shown1996: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,318 citing papers, 36.6% of this breakdownChina: 744 citing papers, 8.2% of this breakdownUnited Kingdom: 440 citing papers, 4.9% of this breakdownFrance: 389 citing papers, 4.3% of this breakdownCanada: 337 citing papers, 3.7% of this breakdownGermany: 337 citing papers, 3.7% of this breakdownAustralia: 252 citing papers, 2.8% of this breakdownIndia: 222 citing papers, 2.4% of this breakdownBrazil: 196 citing papers, 2.2% of this breakdownItaly: 183 citing papers, 2% of this breakdownSwitzerland: 176 citing papers, 1.9% of this breakdownNetherlands: 175 citing papers, 1.9% of this breakdown
0%36.6%Other 25.4%

Institutions

Fields

  • Medicine51.5%
  • Immunology and Microbiology28.8%
  • Biochemistry, Genetics and Molecular Biology15.6%
  • Agricultural and Biological Sciences1.2%
  • Computer Science0.4%
  • Environmental Science0.4%
  • Other2.1%

Topics

  • Mosquito-borne diseases and control11.7%
  • HIV Research and Treatment10.3%
  • Viral Infections and Vectors8.1%
  • HIV/AIDS drug development and treatment4.4%
  • HIV/AIDS Research and Interventions3.5%
  • Immune Cell Function and Interaction3.4%
  • Other58.6%

Coauthors

All papers

Open in search
  1. The continued threat of emerging flaviviruses

    Authors: Theodore C. Pierson, Michael Diamond - Nature Microbiology 2020 cited by 1,115

  2. Modified mRNA Vaccines Protect against Zika Virus Infection

    Authors: Justin M. Richner, Sunny Himansu, Kimberly A. Dowd, Scott L. Butler, Vanessa Salazar, Julie M. Fox, Justin G. Julander, William W. Tang, Sujan Shresta, Theodore C. Pierson, Giuseppe Ciaramella, Michael Diamond - Cell 2017 cited by 907

  3. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

    Authors: Norbert Pardi, Michael J. Hogan, Rebecca S. Pelc, Hiromi Muramatsu, Hanné Andersen, Christina R. DeMaso, Kimberly A. Dowd, Laura L. Sutherland, Richard M. Scearce, Robert Parks, Wendeline Wagner, Alex Granados, Jack Greenhouse, Michelle Walker, Elinor Willis, Jae-Sung Yu, Charles E. McGee, Gregory D. Sempowski, Barbara L. Mui, Ying K. Tam, Yan-Jang S. Huang, Dana L. Vanlandingham, Veronica M. Holmes, Harikrishnan Balachandran, Sujata Sahu, Michelle A. Lifton, Stephen Higgs, Scott E. Hensley, Thomas D. Madden, Michael J. Hope, Katalin Karikó, Sampa Santra, Barney S. Graham, Mark G. Lewis, Theodore C. Pierson, Barton F. Haynes, Drew Weissman - Nature 2017 cited by 894

  4. Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

    Authors: Diana Finzi, Monika Hermankova, Theodore C. Pierson, Lucy M. Carruth, Christopher B. Buck, Richard E. Chaisson, Thomas C. Quinn, Karen Chadwick, Joseph B. Margolick, Ronald Brookmeyer, Joel E. Gallant, Martin Markowitz, David D. Ho, Douglas D. Richman, Robert F. Siliciano - Science 1997 cited by 3,138

  5. 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members

    Authors: Stéphane Daffis, Kristy J. Szretter, Jill Schriewer, LI Jian-qing, Soonjeon Youn, John S. Errett, Tsai‐Yu Lin, Stewart W. Schneller, Roland Züst, Hongping Dong, Volker Thiel, Ganes C. Sen, Volker Fensterl, William B. Klimstra, Theodore C. Pierson, R. Mark L. Buller, Michael Gale, Pei‐Yong Shi, Michael Diamond - Nature 2010 cited by 912

  6. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

    Authors: Diana Finzi, Joel N. Blankson, Janet D. Siliciano, Joseph B. Margolick, Karen Chadwick, Theodore C. Pierson, Kendall A. Smith, Julianna Lisziewicz, Franco Lori, Charles Flexner, Thomas C. Quinn, Richard E. Chaisson, Eric Rosenberg, Bruce D. Walker, Stephen J. Gange, Joel E. Gallant, Robert F. Siliciano - Nature Medicine 1999 cited by 2,141

  7. The emergence of Zika virus and its new clinical syndromes

    Authors: Theodore C. Pierson, Michael Diamond - Nature 2018 cited by 414

  8. The 3.8 Å resolution cryo-EM structure of Zika virus

    Authors: Devika Sirohi, Zhenguo Chen, Lei Sun, Thomas Klose, Theodore C. Pierson, Michael G. Rossmann, Richard Kühn - Science 2016 cited by 753

  9. A CRISPR screen defines a signal peptide processing pathway required by flaviviruses

    Authors: Rong Zhang, Jonathan J. Miner, Matthew J. Gorman, Keiko Rausch, Holly Ramage, James P. White, Adam Zuiani, Ping Zhang, Estefanı́a Fernández, Qiang Zhang, Kimberly A. Dowd, Theodore C. Pierson, Sara Cherry, Michael Diamond - Nature 2016 cited by 386

  10. Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus

    Authors: Pankaj Pal, Kimberly A. Dowd, James D. Brien, Melissa A. Edeling, Sergey Gorlatov, Syd Johnson, Iris Lee, Wataru Akahata, Gary J. Nabel, Mareike K. S. Richter, Jolanda M. Smit, Daved H. Fremont, Theodore C. Pierson, Mark T. Heise, Michael Diamond - PLoS Pathogens 2013 cited by 308

  11. Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targets

    Authors: Nunziata Maio, Bernard A. P. Lafont, Debangsu Sil, Yan Li, J. Martin Bollinger, Carsten Krebs, Theodore C. Pierson, W. Marston Linehan, Tracey A. Rouault - Science 2021 cited by 129

  12. Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

    Authors: Martin R. Gaudinski, Katherine V. Houser, Kaitlyn M. Morabito, Zonghui Hu, Galina V. Yamshchikov, Ro Shauna Rothwell, Nina M. Berkowitz, Floreliz Mendoza, Jamie Saunders, Laura Novik, Cynthia S. Hendel, LaSonji A. Holman, Ingelise J. Gordon, Josephine H. Cox, Srilatha Edupuganti, Monica A. McArthur, Nadine Rouphael, Kirsten E. Lyke, Ginny E. Cummings, Sandra Sitar, Robert T. Bailer, Bryant M. Foreman, Katherine E. Burgomaster, Rebecca S. Pelc, David Gordon, Christina R. DeMaso, Kimberly A. Dowd, Carolyn M. Laurençot, Richard Schwartz, John R. Mascola, Barney S. Graham, Theodore C. Pierson, Julie E. Ledgerwood, Grace Chen, Sarah H. Plummer, Pamela Costner, Kathryn L. Zephir, Joseph P. Casazza, Abidemi Ola, Milalynn Victorino, Carol Levinson, William Whalen, Xiaolin Wang, Jennifer Cunningham, Olga Vasilenko, Maria Burgos Florez, Somia P. Hickman, Iris Pittman, Lam Le, Brenda Larkin, Charla Andrews, Preeti Apte, Renunda Hicks, Cora Trelles Cartagena, Pernell Williams, Catina Boyd, Michelle Conan-Cibotti, Judy Stein, Florence Kaltovich, Hope DeCederfelt, Stacey McAdams, Phyllis Renehan, Wilbur Chen, Nancy Greenberg, Nancy Wymer, Linda Wadsworth, Melissa Billington, Toni Robinson, Colleen Boyce, Faith Pa'ahana Brown, Lisa Chrisley, Alyson Kwon, Prashant Patel, Panagoita Kominou, Brenda Dorsey, Staci Eddington, Shinyi Telscher, Myoughee Lee, Regina Mosely, April Ross, Geoffrey Ford, Briyana Domjahn, Jianguo Xu, Allison Beck, Rebecca Fineman, Shiela Heeke, Jean M. Winter, Shashi Nagar, Colleen F. Kelley, Mark J. Mulligan, Sarah H. Plummer, Pamela Costner, Kathryn L. Zephir, Joseph P. Casazza, Abidemi Ola, Milalynn Victorino, Carol Levinson, William Whalen, Xiaolin Wang, Jennifer Cunningham and 18 more - The Lancet 2017 cited by 304

  13. Effect of a Chikungunya Virus–Like Particle Vaccine on Safety and Tolerability Outcomes

    Authors: Grace Chen, Emily E. Coates, Sarah H. Plummer, Cristina A. Carter, Nina M. Berkowitz, Michelle Conan-Cibotti, Josephine H. Cox, Allison Beck, Mark O’Callahan, Charla Andrews, Ingelise J. Gordon, Brenda Larkin, Rebecca Lampley, Florence Kaltovich, Jason G. Gall, Kevin Carlton, Jason Mendy, Doug Haney, Jeanine May, Amy Bray, Robert T. Bailer, Kimberly A. Dowd, Brittanie Brockett, David Gordon, Richard A. Koup, Richard Schwartz, John R. Mascola, Barney S. Graham, Theodore C. Pierson, Yeycy Donastorg, Nicolas Rosario, Jean W. Pape, Bruno Hoen, André Cabié, Clemente Díaz, Julie E. Ledgerwood, for the VRC 704 Study Team - JAMA 2020 cited by 107

  14. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates

    Authors: Kevin O. Saunders, Norbert Pardi, Robert Parks, Sampa Santra, Zekun Mu, Laura L. Sutherland, Richard M. Scearce, Maggie Barr, Amanda Eaton, Giovanna E. Hernandez, Derrick Goodman, Michael J. Hogan, István Tombácz, David Gordon, Wes Rountree, Yunfei Wang, Mark G. Lewis, Theodore C. Pierson, Chris Barbosa, Ying K. Tam, Gary R. Matyas, Mangala Rao, Zoltán Beck, Xiaoying Shen, Guido Ferrari, Georgia D. Tomaras, David C. Montefiori, Drew Weissman, Barton F. Haynes - npj Vaccines 2021 cited by 83

  15. Structural Basis of Zika Virus-Specific Antibody Protection

    Authors: Haiyan Zhao, Estefanı́a Fernández, Kimberly A. Dowd, Scott D. Speer, Derek J. Platt, Matthew J. Gorman, Jennifer Govero, Christopher A. Nelson, Theodore C. Pierson, Michael Diamond, Daved H. Fremont - Cell 2016 cited by 386

  16. Dengue viruses cluster antigenically but not as discrete serotypes

    Authors: Leah C. Katzelnick, Judith M. Fonville, Gregory D. Gromowski, José Bustos‐Arriaga, Angela Green, Sarah L. James, Louis Lau, Magelda Montoya, Chunling Wang, Laura A. VanBlargan, Colin A. Russell, Hlaing Myat Thu, Theodore C. Pierson, Philippe Buchy, John Aaskov, Jorge L. Muñoz‐Jordán, Nikos Vasilakis, Robert V. Gibbons, Robert B. Tesh, Albert D. M. E. Osterhaus, Ron A. M. Fouchier, Anna P. Durbin, Cameron P. Simmons, Edward C. Holmes, Eva Harris, Stephen S. Whitehead, Derek J. Smith - Science 2015 cited by 247

  17. Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan for Pandemic Preparedness

    Authors: M. Cristina Cassetti, Theodore C. Pierson, L. Jean Patterson, Karin Bok, Amanda J DeRocco, Anne M. Deschamps, Barney S. Graham, Emily J. Erbelding, Anthony S. Fauci - The Journal of Infectious Diseases 2022 cited by 65

  18. Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control

    Authors: Michael S. Diamond, Theodore C. Pierson - Cell 2015 cited by 315

  19. Rapid development of a DNA vaccine for Zika virus

    Authors: Kimberly A. Dowd, Sung‐Youl Ko, Kaitlyn M. Morabito, Eun Sung Yang, Rebecca S. Pelc, Christina R. DeMaso, Leda R. Castilho, Peter Abbink, Michael Boyd, Ramya Nityanandam, David Gordon, John R. Gallagher, Xuejun Chen, John-Paul Todd, Yaroslav Tsybovsky, Audray K. Harris, Yan‐Jang S. Huang, Stephen Higgs, Dana L. Vanlandingham, Hanné Andersen, Mark G. Lewis, Rafael De La Barrera, Kenneth H. Eckels, Richard G. Jarman, Martha Nason, Dan H. Barouch, Mario Roederer, Wing‐Pui Kong, John R. Mascola, Theodore C. Pierson, Barney S. Graham - Science 2016 cited by 401

  20. An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections

    Authors: Laura A. VanBlargan, Sunny Himansu, Bryant M. Foreman, Gregory D. Ebel, Theodore C. Pierson, Michael S. Diamond - Cell Reports 2018 cited by 127

  21. Development of a potent Zika virus vaccine using self-amplifying messenger RNA

    Authors: Kate Luisi, Kaitlyn M. Morabito, Katherine E. Burgomaster, Mayuri Sharma, Wing‐Pui Kong, Bryant M. Foreman, Sonal Patel, Brian E. Fisher, Maya Aleshnick, Jason P. Laliberte, Madison Wallace, Tracy J. Ruckwardt, David N. Gordon, Christine Linton, Nicole Ruggiero, Jessica Cohen, Russell Johnson, Kunal Aggarwal, Sung‐Youl Ko, Eun Sung Yang, Rebecca S. Pelc, Kimberly A. Dowd, Derek T. O’Hagan, Jeffrey B. Ulmer, Sally Mossman, Anna Sambor, Edith Lepine, John R. Mascola, Theodore C. Pierson, Barney S. Graham, Dong Yü - Science Advances 2020 cited by 82

  22. A Zika virus-specific IgM elicited in pregnancy exhibits ultrapotent neutralization

    Authors: Tulika Singh, Kwan‐Ki Hwang, Andrew S. Miller, Rebecca L. Jones, Cesar A. Lopez, Sarah J. Dulson, Camila Giuberti, Morgan A. Gladden, Itzayana G. Miller, Helen Webster, Joshua Eudailey, Kan Luo, Tarra Von Holle, Robert J. Edwards, Sarah Valencia, Katherine E. Burgomaster, Summer L. Zhang, Jesse F. Mangold, Joshua J. Tu, Maria Dennis, S. Munir Alam, Lakshmanane Premkumar, Reynaldo Dietze, Theodore C. Pierson, Eng Eong Ooi, Helen M. Lazear, Richard Kühn, Sallie R. Permar, Mattia Bonsignori - Cell 2022 cited by 41

  23. Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial

    Authors: Lee-Jah Chang, Kimberly A. Dowd, Floreliz Mendoza, Jamie Saunders, Sandra Sitar, Sarah H. Plummer, Galina V. Yamshchikov, Uzma Sarwar, Zonghui Hu, Mary E. Enama, Robert T. Bailer, Richard A. Koup, Richard Schwartz, Wataru Akahata, Gary J. Nabel, John R. Mascola, Theodore C. Pierson, Barney S. Graham, Julie E. Ledgerwood - The Lancet 2014 cited by 249

  24. A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection

    Authors: Theodore C. Pierson, Melissa D. Sánchez, Bridget A. Puffer, Asim Ahmed, Brian J. Geiss, Laura Valentine, Louis A. Altamura, Michael Diamond, Robert W. Doms - Virology 2005 cited by 229